MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study. (Q48617165)
Jump to navigation
Jump to search
scientific article published on 11 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study. |
scientific article published on 11 March 2012 |
Statements
MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study (English)
Young Suk Kim
Se Hoon Kim
Jun Won Kim
Jong Hee Chang
Dong Suk Kim
11 March 2012